INS and Hypoglycemia: A common theme on the insulin dosing DSSs which have been evaluated in human studies is that, thus far, they have been effective at reducing glycemic variability and reducing hypoglycemia with short-term use, but they have not yet shown similar improvements in HbA1c, time in range, or mean glucose that AID systems have demonstrated.